Clinical Trials Browser

Recruiting × NETWORK × Burkitt Lymphoma × Clear all

NCT02981628 2026-02-23

Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia

Phase 2 Recruiting

80 enrolled 1 FDA

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

NCT06635330 2024-10-10

Safety and Efficacy of CAR T Cell Therapy in Patients with R/r B-ALL

Phase 1/2 Recruiting

Burkitt Lymphoma, Recurrence